Achromatopsia

En Español
Get updates on Achromatopsia

Achromatopsia is an inherited retinal disease causing loss of visual acuity as well as central and color vision and vision in lighted conditions.

Jump to Section

What is Achromatopsia?

Achromatopsia is an inherited retinal condition causing extreme light sensitivity (i.e., day blindness), as well as reduced visual acuity and color discrimination. Achromatopsia is caused by mutations in any of several genes. The most common genes associated with the condition are the CNGB3 and CNGA3 genes — mutations in these cause about 75 percent of cases.

Symptoms

Achromatopsia causes extreme light sensitivity (i.e., day blindness), as well as reduced visual acuity and color discrimination. People with the condition wear glasses with tinted lenses to filter out the type of light that is uncomfortable. Different patients have different light-filtering needs.

What to expect with Achromatopsia: Extreme Light Sensitivity; Reduced Visual Acuity; Color Discrimination. People with the condition wear glasses with tinted lenses to filter out the type of light that is uncomfortable. Different patients have different light-filtering needs.

Inheritance

Achromatopsia is caused by mutations in one of a few genes. The most common genes associated with the condition are the CNGB3 and CNGA3 genes — mutations in these cause about 75 percent of cases. Mutations in GNAT2, PDE6C, and PDE6H can also cause the disease.

How is Achromatopsia Inherited? HOW IS ACHROMATOPSIA INHERITED? Achromatopsia is inherited when both parents have one mutated copy of a specific gene such as CNGB3 or CNGA3 and one normal copy. The child has a 25% chance of inheriting the two copies of the mutated gene, (from each parent) causing the disease. GENETIC TESTING: Genetic testing for achromatopsia is available. It helps assess the risk of passing the disorder from parent to offspring. It also helps with attaining an accurate diagnosis. A patient with an accurate diagnosis is in a better position to understand which emerging treatment approaches and clinical trials are most appropriate.

The condition is passed down through the autosomal recessive inheritance pattern. In autosomal recessive diseases, both parents carry one copy of the mutated gene and one normal copy, but have no symptoms themselves. They are therefore referred to as unaffected carriers. Each of their children has a 25 percent chance of being affected by inheriting a mutated copy from each parent. If the child inherits one mutated copy from one parent, they will be an unaffected carrier.

Living with the Disease

There are many services and accommodative and assistive resources available to people and families with achromatopsia. Visit the Foundation’s Low Vision Resources page to learn about many of these resources. A low vision specialist can help recommend the resources that are right for you.

Genetic Testing

Genetic testing is available for achromatopsia. It helps assess the risk of passing the disorder from parent to offspring. It also helps with attaining an accurate diagnosis. A patient with an accurate diagnosis is in a better position to understand which emerging treatment approaches and clinical trials are most appropriate for them.

The information provided by the Foundation Fighting Blindness is for educational purposes only and is not intended as medical advice. Some of the information provided has been obtained from widely used third-party public sources, but the Foundation is unable to independently verify the accuracy of all of such information. The Foundation does not endorse any specific treatment, product, clinical trial, company, or provider, including those mentioned in our content or featured through our partners and sponsors. Every person's condition is unique. Please talk with your qualified eye care professional about the treatment options that are right for you.

Next Section

Read the Most Recent Research on Achromatopsia

Jump to Section

Latest News

All News